Sarepta’s new CEO Michael Severino faces critical milestones to prove growth

In his first earnings call just days after becoming Sarepta Therapeutics' CEO, Michael Severino recognized that the rare disease drugmaker faces multiple upcoming milestones that will clarify its growth trajectory.